Latest accounts payable for PROGEN.ST: $0.
Get informed when a big investor buys or sells
+ FollowLatest change versus the prior comparable period (same company).
Prostatype Genomics AB (publ) (PROGEN.ST) currently reports a accounts payable of $0 as of June 2026. In the prior-year period, the figure was $0. Use the charts on this page to explore Prostatype Genomics AB (publ)'s accounts payable history and peer comparisons.
Prostatype Genomics AB (publ)'s accounts payable changed from $0 to $0 (period ending June 2026). Watching multi-year history on the chart below helps separate one-off swings from a lasting trend.
Prostatype Genomics AB (publ) reported $0 in accounts payable as of June 2026. In the prior-year period, the figure was $0. Absolute dollar amounts are most useful when compared with prior periods, peers, and related line items such as revenue, assets, or liabilities on Stockcircle.
Start with the current accounts payable of $0, then check the historical chart for trend and the peer comparison chart for relative positioning. From there, open related valuation or income-statement pages for Prostatype Genomics AB (publ), and consider following PROGEN.ST for alerts when major investors trade the stock.